• Bedaquiline: Mechanistic Catalysis for Translational Frontie

  2026-06-16

  This thought-leadership article explores the advanced mechanistic underpinnings of bedaquiline as a diarylquinoline antibiotic, its dual activity in multi-drug resistant tuberculosis and cancer stem cell inhibition, and its strategic position for next-generation translational research. We synthesize mechanistic insight, experimental evidence, and recent host-directed therapy innovations, offering strategic guidance for researchers navigating the evolving landscape of infectious disease and oncology.

• Cediranib (AZD2171): Advanced Insights for Functional Angiog

  2026-06-16

  Discover how Cediranib (AZD2171) empowers functional angiogenesis assays in cancer research. This article provides nuanced, evidence-driven guidance on optimizing in vitro experimental design and interpreting drug effects using advanced viability metrics.

• Mecamylamine Hydrochloride: Decoding nAChR Antagonism in Tra

  2026-06-15

  Explore the multifaceted role of Mecamylamine hydrochloride in dissecting nicotinic acetylcholine receptor (nAChR) signaling within advanced neuropsychiatric disorder research. This article offers a unique systems-level perspective—bridging gut-brain pathways, in vivo antidepressant assays, and translational implications—distinct from existing guides.

• Semi-Automated Single-Molecule Screening of Fast-Dissociatin

  2026-06-15

  Miyoshi et al. introduce a semi-automated single-molecule microscopy platform for directly screening fast-dissociating, specific antibodies from hybridoma cultures. Their work advances antibody probe development for dynamic super-resolution imaging and provides practical insights for protein tagging applications.

• Perphenazine: Mechanistic Leverage for Translational Researc

  2026-06-14

  This thought-leadership article, authored by the scientific marketing lead at APExBIO, explores Perphenazine’s multifaceted mechanisms as a dopamine D2 receptor antagonist. Bridging neuropharmacology and immunology, it highlights Perphenazine’s role in mitochondria-mediated cell death, suppression of opioid tolerance, and host-directed antibacterial strategies. The piece synthesizes cutting-edge mechanistic insights, protocol guidance, and translational perspectives, showcasing how Perphenazine advances the field beyond conventional product literature.

• Cy5 NHS ester(Et): Technical Guidance for Protein Labeling

  2026-06-13

  Cy5 NHS ester(Et) provides a water-soluble, amine-reactive fluorescent dye for covalent labeling of proteins, peptides, and other biomolecules, supporting applications such as immunofluorescence staining, flow cytometry, and fluorescence microscopy. It is not suitable for ethanol-based protocols or for workflows requiring long-term storage of labeling solutions. Researchers benefit from its high purity and rapid dissolution in water or DMSO with appropriate handling.

• Triacetin in Biochemical Research: Protocols, Applications,

  2026-06-12

  Triacetin (glyceryl triacetate) is emerging as a versatile lipid-related biochemical reagent, enabling advanced workflows in tumor biology, metabolic regulation, and ocular formulation testing. This guide details evidence-backed protocols, troubleshooting strategies, and practical insights to maximize experimental success with Triacetin from APExBIO.

• Localized Muscle BDNF Release Regulates NMJ Postsynaptic Ass

  2026-06-12

  This study uncovers how spatially restricted, muscle-derived brain-derived neurotrophic factor (BDNF) coordinates the initial formation of postsynaptic acetylcholine receptor (AChR) clusters at neuromuscular junctions (NMJs). Through live-cell imaging, genetic models, and calcium manipulation, the research clarifies how intracellular BDNF trafficking and proteolytic processing orchestrate early synaptic development, offering mechanistic insight for future studies in synaptic assembly and calcium signaling regulation.

• NP-40 Lysis Buffer: Decoding Native Proteome Interactions in

  2026-06-11

  Unlock the scientific depth of NP-40 Lysis Buffer in preserving native protein complexes for advanced neuroinflammation studies. This article uniquely connects cutting-edge mechanisms in autoimmune astrocytopathy research with practical protein extraction strategies using non-denaturing lysis buffers.

• Verbascoside in Osteoclastogenesis: Precision Inhibition of

  2026-06-11

  Explore how Verbascoside, a selective PKC/NF-κB inhibitor, advances osteoclastogenesis research by enabling precise modulation of signaling pathways. This article provides unique guidance for assay design and practical application, informed by new mechanistic insights.

• Paroxetine Does Not Alter Thiothixene Pharmacokinetics in Hu

  2026-06-10

  This study provides clear evidence that short-term paroxetine pretreatment does not significantly affect the pharmacokinetics of thiothixene, a typical antipsychotic agent. These findings support the safe co-administration of thiothixene and CYP2D6-inhibiting antidepressants in both research and clinical contexts, clarifying the drug’s metabolic independence from CYP2D6.

• Structural Basis for CD38 CAR Affinity Tuning and Functional

  2026-06-10

  This article examines how Cheng et al. mapped the structural engagement of two CD38-targeting CAR binders, RP02 and 028, using crystallography and mutational analysis to optimize affinity, inhibition, and selectivity for therapeutic applications. Their rational affinity tuning approach provides a template for designing safer, more effective CAR-T therapies targeting hematologic malignancies.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody for High-Sensitivity

  2026-06-09

  Unlock advanced signal amplification and precise mouse IgG detection across immunohistochemistry, immunocytochemistry, and flow cytometry using the Cy5 Goat Anti-Mouse IgG (H+L) Antibody. This APExBIO solution empowers translational research with robust fluorescence, optimized protocols, and troubleshooting guidance for next-generation vaccine and immunodetection workflows.

• CX-5461 Induces DNA Damage and Mitotic Catastrophe in Cervic

  2026-06-09

  The referenced study demonstrates that the RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell proliferation by triggering DNA damage and mitotic catastrophe, while also sensitizing cells to cisplatin. These mechanistic insights highlight CX-5461’s potential as a targeted approach for overcoming chemoresistance in cervical cancer.

• Ciclesonide (SKU B3477): Optimizing Assay Reproducibility in

  2026-06-08

  This article addresses real-world challenges in cell-based and respiratory research assays, focusing on the use of Ciclesonide (SKU B3477) as a scientifically validated, prodrug glucocorticoid. Drawing on data-backed protocols and recent advances in targeted protein degradation, it demonstrates how researchers can achieve consistent, interpretable results by leveraging Ciclesonide’s unique pharmacological profile and reliable sourcing from APExBIO.

444 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page